These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30527899)

  • 1. New Challenges for Hypertension Treatment.
    Rosas-Peralta M; Jiménez-Genchi GM
    Arch Med Res; 2018 Nov; 49(8):548-557. PubMed ID: 30527899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-Analysis: Intensive BP Control Decreases Major CV Events and Stroke, but Not MI, Heart Failure, or Mortality.
    Barry HC
    Am Fam Physician; 2016 Jun; 93(12):1036-7. PubMed ID: 27304776
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.
    Mancia G; Kjeldsen SE; Zappe DH; Holzhauer B; Hua TA; Zanchetti A; Julius S; Weber MA
    Eur Heart J; 2016 Mar; 37(12):955-64. PubMed ID: 26590384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Hypertension and Lowering Blood Pressure for Prevention of Cardiovascular Disease Events.
    Viera AJ
    Med Clin North Am; 2017 Jul; 101(4):701-712. PubMed ID: 28577621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current approaches to the treatment of hypertension in older persons.
    Aronow WS
    Postgrad Med; 2012 Jan; 124(1):50-9. PubMed ID: 22314114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study.
    Khera R; Lu Y; Lu J; Saxena A; Nasir K; Jiang L; Krumholz HM
    BMJ; 2018 Jul; 362():k2357. PubMed ID: 29997129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hypertension in 2017: targets and therapies.
    Ahluwalia M; Bangalore S
    Curr Opin Cardiol; 2017 Jul; 32(4):413-421. PubMed ID: 28346238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
    Bangalore S; Messerli FH; Franklin SS; Mancia G; Champion A; Pepine CJ
    Eur Heart J; 2009 Jun; 30(11):1395-401. PubMed ID: 19351690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [120 mmHg for everyone?].
    Wiersma T
    Ned Tijdschr Geneeskd; 2016; 160():A9894. PubMed ID: 27071362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Hypertension: Which Goal for Which Patient?
    Jarraya F
    Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
    Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
    Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary Drug Treatment of Hypertension: Focus on Recent Guidelines.
    Aronow WS; Frishman WH
    Drugs; 2018 Apr; 78(5):567-576. PubMed ID: 29536372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vital signs: prevalence, treatment, and control of hypertension--United States, 1999-2002 and 2005-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Feb; 60(4):103-8. PubMed ID: 21293325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of more intensive versus less intensive blood pressure control. Updated trial sequential analysis.
    Reboldi G; Angeli F; Gentile G; Verdecchia P
    Eur J Intern Med; 2022 Jul; 101():49-55. PubMed ID: 35397950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.
    Brouwer TF; Vehmeijer JT; Kalkman DN; Berger WR; van den Born BH; Peters RJ; Knops RE
    Diabetes Care; 2018 Jun; 41(6):1142-1148. PubMed ID: 29212825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.
    Hansson L; Lindholm LH; Ekbom T; Dahlöf B; Lanke J; Scherstén B; Wester PO; Hedner T; de Faire U
    Lancet; 1999 Nov; 354(9192):1751-6. PubMed ID: 10577635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Reboussin DM; Allen NB; Griswold ME; Guallar E; Hong Y; Lackland DT; Miller EPR; Polonsky T; Thompson-Paul AM; Vupputuri S
    Hypertension; 2018 Jun; 71(6):e116-e135. PubMed ID: 29133355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP.
    Buckley LF; Dixon DL; Wohlford GF; Wijesinghe DS; Baker WL; Van Tassell BW
    Diabetes Care; 2017 Dec; 40(12):1733-1738. PubMed ID: 28947569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Uneven sex distribution in the cardiovascular trials--an exaggerated problem].
    Melander H; Rastad JA
    Lakartidningen; 2006 Jun 8-13; 103(23):1856-9. PubMed ID: 16838599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.